Tomita Pharmaceutical Co., Ltd.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
2
Ending by 2030
Jun 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Apr 6, 2027The maintenance fee for Core particle for pharmaceutical preparation (US 9,149,434) comes due Apr 6, 2027. Unpaid by Oct 6, 2027, it lapses early.
- 1 fee due Jun 30, 2027The maintenance fee for Powder composition containing oily substance (US 10,517,825) comes due Jun 30, 2027. Unpaid by Jan 3, 2028, it lapses early.
- 3 fees due Jul 7 to 14, 2027 · next Jul 7
Recent changes
- 1 of the patents on this record was granted since Aug 21, 2026
- Nov 17 US 12,799,340 Calcium Phosphate Powder
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,473,300 | Moisture absorbent composition, moisture absorbent molding, and method for controlling equilibrium humidity, method for controlling time of maintaining equilibrium humidity In force · USPTO record | In force | USPTO record | |
| US 9,149,434 | Core particle for pharmaceutical preparation In force · USPTO record | In force | USPTO record | |
| US 8,679,547 | Method for manufacturing calcium silicate based composition In force · USPTO record | In force | USPTO record | |
| US 8,980,330 | Method for manufacturing calcium silicate based composition In force · USPTO record | In force | USPTO record | |
| US 10,251,988 | Dialysis agent a containing acetic acid and acetate salt, and a two-part dialysis agent using thereof In force · USPTO record | In force | USPTO record | |
| US 9,931,453 | Dialysis agent a containing acetic acid and acetate salt, and a two-part dialysis agent using thereof In force · USPTO record | In force | USPTO record | |
| US 9,463,266 | Preparation apparatus and preparation method for dialysis fluid of variable bicarbonate ion concentration type, dialysate of variable bicarbonate ion concentration type, and dialysis system of variable bicarbonate ion concentration type In force · USPTO record | In force | USPTO record | |
| US 10,525,078 | Solid dialysis A agent containing alkali metal diacetate, and two-part type low-acetate dialysis agent using same In force · USPTO record | In force | USPTO record | |
| US 11,124,420 | Powdered gyrolite-type calcium silicate having high oil absorbency and large particle diameter, and production method therefor In force · USPTO record | In force | USPTO record | |
| US 10,292,913 | Powdered Tobermorite-Type Calcium Silicate-Based Material and Method for Producing Same In force · High confidence | In force | High confidence |
Also on record, not counted in the 16: 5 lapsed for an unpaid fee · 12 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 3 no status recorded